Pitching Endpoints News Technology Reporters: Vertical Press Strategy
Endpoints News is a subscriber-driven biopharma newsroom where technology coverage sits at the intersection of R&D, data, and drug development economics. Pitch the science-to-business consequence, not the product feature.
This guide is built for PR teams working the Endpoints News Technology reporters desk — where precision, exclusivity, and news velocity decide who gets a reply.
Editorial Scope: What Endpoints News Covers in Technology#
Endpoints treats "technology" as the tools and platforms reshaping how drugs get discovered, tested, and commercialized. That means AI/ML in discovery, clinical trial infrastructure, real-world data, biotech software, lab automation, and manufacturing tech.
It is not a consumer health-tech or gadget beat. If your story has no clear line to biopharma R&D or commercialization, it belongs elsewhere.
Strong fits: platform launches with named pharma partners, validation data, regulatory precedent (FDA guidance on AI), and tooling that changes trial timelines or cost structures.
Weak fits: wellness apps, hospital IT procurement, and anything that reads as a vendor press release.
💡 Vertical Pro Tip: Endpoints readers are industry operators who already know the science. Skip the 101 explainer and lead with the implication — a one-sentence "why this changes the math" beats three paragraphs of background.
Identifying Active Writers on the Endpoints News Technology Reporters List#
Seven-plus journalists actively touch this beat, and bylines rotate fast. Pull a fresh Endpoints News Technology reporters list before every campaign rather than reusing last quarter's spreadsheet.
In our directory, representative writers include Anna Brown, Kyle LaHucik, Jaimy Lee, and Lydia Pflanzer. Each carries a distinct center of gravity — deals and financing, medtech and market access, platform science — so match your angle to the byline, not the beat label.
Read their last five pieces. If they've covered your category twice in a month, they're saturated; if they've never touched it, you're either early or off-scope.
| Factor | Recommended Strategy | What Gets Ignored |
|---|---|---|
| Beat alignment | Tie tech to R&D cost, trial speed, or approval pathway | Generic "digital transformation" framing |
| News hook | Exclusive data, named partner, regulatory milestone | "Company announces platform update" |
| Timing | Pitch 6–10 a.m. ET, mid-week, ahead of news cycles | Friday afternoon drops and post-conference blasts |
| Sourcing | Named executives plus an independent expert | Anonymous "industry sources" only |
| Follow-up | One concise nudge after 72 hours | Multi-email sequences and phone escalation |
Angles & Data Points That Resonate With Endpoints News Technology Journalists#
This audience rewards specificity. Bring numbers a reporter can put in a lede: trial acceleration in months, cost per patient, failure-rate deltas, adoption counts across named biotechs.
Winning angles:
- A platform that cut a Phase I timeline, with the underlying dataset.
- Pharma partnership economics — upfronts, milestones, why the buyer chose this vendor.
- Regulatory friction: what FDA's latest AI or software guidance actually changes.
- Contrarian takes: where AI in discovery has underdelivered, and who's admitting it.
Losing angles: "revolutionary," "game-changing," and any claim without a baseline. Endpoints Endpoints News Technology journalists are professional skeptics — vague superlatives read as a red flag.
Offer the reporter something proprietary: early access to a dataset, a first interview with a departing exec, or a look at internal benchmark numbers.
Outreach Protocols & Accessing Endpoints News Technology Journalists Contacts#
Verified Endpoints News Technology journalists contacts come from byline pages, newsletter mastheads, and conference press lists — not scraped databases. Confirm the current title and beat before you send.
Keep the first email under 150 words: subject line with the news peg, two-sentence pitch, one proof point, and a link to supporting data. No attachments on first contact.
Practical tips:
- Mirror the outlet's voice — direct, numerate, allergic to hype.
- Offer an exclusive window and state it explicitly ("offered to you first, 48 hours").
- If they pass, ask what would make it work later; Endpoints reporters do answer that.
- Respect the paywall: don't pitch stories that depend on public clicks.
Never pitch the same exclusive to two Endpoints reporters on the same beat. The newsroom talks, and you lose both.
Fast-Action Pitch Checklist for Technology#
Run this before every send. It takes four minutes and saves the relationship.
- Angle ties to R&D economics, trial infrastructure, or regulatory change
- Reporter confirmed on the current Endpoints News Technology reporters list
- One proprietary data point included, with baseline
- Named executive available for interview within 48 hours
- Subject line states the news, not the company name
- Under 150 words, no attachments, single link
- Exclusive or first-look terms stated plainly
- Sent 6–10 a.m. ET, Tuesday through Thursday
Bottom line: pitch the consequence to biopharma, arm the reporter with numbers, and make their job faster. That's how you stay on the shortlist with the Endpoints News Technology reporters who matter.